Motley Fool Staff

This fast-growing biotech is on track for significant earnings growth.

A small biotech is on the cusp of a big market opportunity.

Data from a highly anticipated trial shows a remarkable ability to reduce the risk of heart attack or stroke.

Listener Jay realizes he's been buying and selling based more on hopes and a compelling story than on data, real revenue, and such, and he's looking to change that.

The owner of Arby's and Buffalo Wild Wings thinks the drive-in chain will be a good fit for its portfolio.

And what does this luxury brand acquisition signal about the company's strategy?

Why we're interested in a REIT and a fintech giant.

Square is becoming a lot more than a payment-processing company.

The average homeowner's equity is up by a five-figure sum over the past year alone.

The e-commerce titan could offer a checking account product of its own, but will there be even more to come?

Why does Facebook care about your financial data?

Congress will give the federal agency a bit more room on the consumer protection front, but only a bit.

The last company standing in the satellite radio game will merge with the No. 3 music streaming service.

On Saturday, the cable giant offered $39 billion for the European pay-TV provider -- and Disney shareholders should be thrilled.

Our trio of analysts explain why they think you should keep an eye on these companies.

The IPO debuted strongly, but it’s playing in a sandbox where larger players have serious clout.

All-you-can-eat breadsticks? Thumbs up. Biscuits? Answer unclear, ask again later.

It’s never good to hear about people losing their jobs, but the athletic-gear maker really needed to adjust its strategy and its headcount.

The market has one view of the shipper, the Fools have another. But there's no two ways of reading the latest numbers on Disney's streaming sports app.

It appears the market approves of the medical device company's purchase. But in the grocery space, the top supplier to Whole Foods is sputtering.